Signaling	O
events	O
induced	O
by	O
lipopolysaccharide-activated	B-protein
toll-like	I-protein
receptor	I-protein
2	I-protein
.	O

Human	B-protein
Toll-like	I-protein
receptor	I-protein
2	I-protein
(	I-protein
TLR2	I-protein
)	I-protein
is	O
a	O
signaling	B-protein
receptor	I-protein
that	O
responds	O
to	O
LPS	O
and	O
activates	O
NF-kappaB	B-protein
.	O

Here	O
,	O
we	O
investigate	O
further	O
the	O
events	O
triggered	O
by	O
TLR2	B-protein
in	O
response	O
to	O
LPS	O
.	O

We	O
show	O
that	O
TLR2	B-protein
associates	O
with	O
the	O
high-affinity	B-protein
LPS	I-protein
binding	I-protein
protein	I-protein
membrane	O
CD14	B-protein
to	O
serve	O
as	O
an	O
LPS	B-protein
receptor	I-protein
complex	I-protein
,	O
and	O
that	O
LPS	O
treatment	O
enhances	O
the	O
oligomerization	O
of	O
TLR2	B-protein
.	O

Concomitant	O
with	O
receptor	O
oligomerization	O
,	O
the	O
IL-1R-associated	B-protein
kinase	I-protein
(	I-protein
IRAK	I-protein
)	I-protein
is	O
recruited	O
to	O
the	O
TLR2	B-protein
complex	O
.	O

Intracellular	O
deletion	O
variants	O
of	O
TLR2	B-protein
lacking	O
C-terminal	O
13	O
or	O
141	O
aa	O
fail	O
to	O
recruit	O
IRAK	B-protein
,	O
which	O
is	O
consistent	O
with	O
the	O
inability	O
of	O
these	O
mutants	O
to	O
transmit	O
LPS	O
cellular	O
signaling	O
.	O

Moreover	O
,	O
both	O
deletion	O
mutants	O
could	O
still	O
form	O
complexes	O
with	O
wild-type	B-protein
TLR2	I-protein
and	O
act	O
in	O
a	O
dominant-negative	O
(	O
DN	O
)	O
fashion	O
to	O
block	O
TLR2	B-protein
-mediated	O
signal	O
transduction	O
.	O

DN	O
constructs	O
of	O
myeloid	B-protein
differentiation	I-protein
protein	I-protein
,	O
IRAK	B-protein
,	O
TNF	B-protein
receptor-associated	I-protein
factor	I-protein
6	I-protein
,	O
and	O
NF-kappaB-inducing	B-protein
kinase	I-protein
,	O
when	O
coexpressed	O
with	O
TLR2	B-protein
,	O
abrogate	O
TLR2	B-protein
-mediated	O
NF-kappaB	B-protein
activation	O
.	O

These	O
results	O
reveal	O
a	O
conserved	O
signaling	O
pathway	O
for	O
TLR2	B-protein
and	O
IL-1Rs	B-protein
and	O
suggest	O
a	O
molecular	O
mechanism	O
for	O
the	O
inhibition	O
of	O
TLR2	B-protein
by	O
DN	O
variants	O
.	O

-	NULL
.	NULL

_-	NULL
The	NULL
Attune	NULL
``	NULL
NxT	NULL
Flow	NULL
Cytometer	NULL
system	NULL
--	NULL
-	NULL
Let	NULL
's	NULL
get	NULL
to	NULL
the	NULL
science	NULL
2	NULL
,	NULL
n	NULL
l	NULL
-se	NULL
[	NULL
invitrogen	NULL
Signaling	NULL
Events	NULL
Induced	NULL
by	NULL
f	NULL
-	NULL
<	NULL
The	NULL
1	NULL
o	NULL
leﬁrijllgﬁzhélo	NULL
gy	NULL
Lipopolysaccharide-	NULL
Activated	NULL
Toll-Like	NULL
Receptor	NULL
2	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Ruey-Bing	NULL
Yang	NULL
,	NULL
Melanie	NULL
R.	NULL
Mark	NULL
,	NULL
Austin	NULL
L.	NULL
Gurney	NULL
and	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Paul	NULL
J.	NULL
Godowski	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:639-643	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/2/639	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
35	NULL
articles	NULL
,	NULL
16	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.jimmunol.org/content/163/2/639	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Signaling	NULL
Events	NULL
Induced	NULL
by	NULL
Lipopolysaccharide-Activated	NULL
Toll-Like	NULL
Receptor	NULL
2	NULL
Ruey-Bing	NULL
Yang	NULL
,	NULL
Melanie	NULL
R.	NULL
Mark	NULL
,	NULL
Austin	NULL
L.	NULL
Gurney	NULL
,	NULL
and	NULL
Paul	NULL
J.	NULL
Godowski	NULL
'	NULL
Human	NULL
Toll-like	NULL
receptor	NULL
2	NULL
(	NULL
TLR2	NULL
)	NULL
is	NULL
a	NULL
signaling	NULL
receptor	NULL
that	NULL
responds	NULL
to	NULL
LPS	NULL
and	NULL
activates	NULL
NF-xB	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
investigate	NULL
further	NULL
the	NULL
events	NULL
triggered	NULL
by	NULL
TLR2	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

We	NULL
show	NULL
that	NULL
TLR2	NULL
associates	NULL
with	NULL
the	NULL
high-affinity	NULL
LPS	NULL
binding	NULL
protein	NULL
membrane	NULL
CD14	NULL
to	NULL
serve	NULL
as	NULL
an	NULL
LPS	NULL
receptor	NULL
complex	NULL
,	NULL
and	NULL
that	NULL
LPS	NULL
treatment	NULL
enhances	NULL
the	NULL
oligomerization	NULL
of	NULL
TLR2	NULL
.	NULL

Concomitant	NULL
with	NULL
receptor	NULL
oligomerization	NULL
,	NULL
the	NULL
IL-1R-associated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
TLR2	NULL
complex	NULL
.	NULL

Intracellular	NULL
deletion	NULL
variants	NULL
of	NULL
TLR2	NULL
lacking	NULL
C-terminal	NULL
13	NULL
or	NULL
141	NULL
aa	NULL
fail	NULL
to	NULL
recruit	NULL
IRAK	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
these	NULL
mutants	NULL
to	NULL
transmit	NULL
LPS	NULL
cellular	NULL
signaling	NULL
.	NULL

Moreover	NULL
,	NULL
both	NULL
deletion	NULL
mutants	NULL
could	NULL
still	NULL
form	NULL
complexes	NULL
with	NULL
wild-type	NULL
TLR2	NULL
and	NULL
act	NULL
in	NULL
a	NULL
dominant-negative	NULL
(	NULL
DN	NULL
)	NULL
fashion	NULL
to	NULL
block	NULL
TLR2-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

DN	NULL
constructs	NULL
of	NULL
myeloid	NULL
differentiation	NULL
protein	NULL
,	NULL
IRAK	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
6	NULL
,	NULL
and	NULL
kinase	NULL
,	NULL
when	NULL
coexpressed	NULL
with	NULL
TLR2	NULL
,	NULL
abrogate	NULL
TLR2-mediated	NULL
NF-B	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
a	NULL
conserved	NULL
signaling	NULL
pathway	NULL
for	NULL
TLR2	NULL
and	NULL
IL-1Rs	NULL
and	NULL
suggest	NULL
a	NULL
molecular	NULL
mechanism	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
TLR2	NULL
by	NULL
DN	NULL
variants	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
:	NULL
639-643.	NULL
embers	NULL
of	NULL
the	NULL
human	NULL
Toll-like	NULL
receptor	NULL
(	NULL
TLR	NULL
)	NULL
family	NULL
M	NULL
share	NULL
a	NULL
similar	NULL
topography	NULL
with	NULL
an	NULL
extracellular	NULL
do	NULL
main	NULL
(	NULL
ECD	NULL
)	NULL
containing	NULL
multiple	NULL
leucine	NULL
rich-repeats	NULL
,	NULL
a	NULL
single	NULL
membrane-spanning	NULL
domain	NULL
,	NULL
and	NULL
an	NULL
intracellular	NULL
domain	NULL
with	NULL
significant	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
IL-1R	NULL
family	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Toll	NULL
was	NULL
originally	NULL
identified	NULL
in	NULL
Drosophila	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
establishment	NULL
of	NULL
dorsoventral	NULL
polarity	NULL
in	NULL
the	NULL
embryo	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Toll	NULL
also	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
innate	NULL
immunity	NULL
,	NULL
inducing	NULL
an	NULL
antimicrobial	NULL
response	NULL
in	NULL
the	NULL
adult	NULL
fly	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Human	NULL
sepsis	NULL
is	NULL
responsible	NULL
for	NULL
>	NULL
20,000-50,000	NULL
deaths	NULL
per	NULL
year	NULL
in	NULL
the	NULL
United	NULL
States	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
sepsis	NULL
induced	NULL
by	NULL
Gram-negative	NULL
bacteria	NULL
,	NULL
host	NULL
cells	NULL
sense	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
(	NULL
en-dotoxin	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
major	NULL
cell	NULL
wall	NULL
component	NULL
of	NULL
the	NULL
invading	NULL
pathogen	NULL
,	NULL
and	NULL
mount	NULL
a	NULL
dysregulated	NULL
innate	NULL
immune	NULL
response	NULL
resulting	NULL
in	NULL
pathophysiological	NULL
consequences	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Macrophages	NULL
and	NULL
monocytes	NULL
respond	NULL
to	NULL
LPS	NULL
by	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
cyto-kines	NULL
,	NULL
cell	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
low-m.w	NULL
.	NULL

proinflammatory	NULL
molecules	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
monocytes/macrophages	NULL
by	NULL
LPS	NULL
requires	NULL
a	NULL
serum	NULL
protein	NULL
known	NULL
as	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
and	NULL
a	NULL
GPI-anchored	NULL
cell-surface	NULL
protein	NULL
,	NULL
CD14	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
until	NULL
recently	NULL
,	NULL
little	NULL
was	NULL
known	NULL
about	NULL
how	NULL
the	NULL
LPS	NULL
signal	NULL
is	NULL
transduced	NULL
across	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
9	NULL
)	NULL
.	NULL

A	NULL
role	NULL
for	NULL
TLRs	NULL
in	NULL
this	NULL
process	NULL
was	NULL
initially	NULL
suggested	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
one	NULL
human	NULL
TLR	NULL
(	NULL
TLR4	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
proposed	NULL
that	NULL
human	NULL
TLRs	NULL
may	NULL
regulate	NULL
innate	NULL
immunity	NULL
and	NULL
signal	NULL
the	NULL
activation	NULL
of	NULL
adapted	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Genentech	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94080	NULL
Received	NULL
for	NULL
publication	NULL
March	NULL
3	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
27	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Paul	NULL
J.	NULL
Godowski	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Genentech	NULL
,	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94080-4990	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
ski	NULL
@	NULL
gene.com	NULL
?	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
TLR	NULL
,	NULL
Toll-like	NULL
receptor	NULL
;	NULL
MyD88	NULL
,	NULL
myeloid	NULL
differentiation	NULL
protein	NULL
;	NULL
IRAK	NULL
,	NULL
IL-1R-associated	NULL
kinase	NULL
;	NULL
TRAF	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
;	NULL
CNTFR	NULL
,	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
receptor	NULL
;	NULL
WT	NULL
,	NULL
wild	NULL
type	NULL
;	NULL
LBP	NULL
,	NULL
LPS-binding	NULL
protein	NULL
;	NULL
ECD	NULL
,	NULL
extracellular	NULL
domain	NULL
;	NULL
NIK	NULL
,	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
;	NULL
DN	NULL
,	NULL
dominant-negative	NULL
;	NULL
mCD14	NULL
,	NULL
membrane	NULL
CD14	NULL
;	NULL
RIP	NULL
,	NULL
receptor-interacting	NULL
protein	NULL
;	NULL
gD	NULL
,	NULL
HSV	NULL
type	NULL
1	NULL
glycoprotein	NULL
D.	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
immunity	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
precise	NULL
functions	NULL
of	NULL
these	NULL
TLRs	NULL
remain	NULL
unclear	NULL
.	NULL

We	NULL
and	NULL
others	NULL
showed	NULL
recently	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
TLR2	NULL
renders	NULL
LPS	NULL
responsiveness	NULL
to	NULL
otherwise	NULL
LPS-unresponsive	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
LPS	NULL
response	NULL
mediated	NULL
by	NULL
TLR2	NULL
requires	NULL
the	NULL
plasma	NULL
protein	NULL
LBP	NULL
and	NULL
is	NULL
greatly	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
cell	NULL
surface	NULL
CD14	NULL
(	NULL
membrane	NULL
CD14	NULL
(	NULL
mCD14	NULL
)	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
LPS	NULL
treatment	NULL
of	NULL
TLR2-expressing	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
in	NULL
a	NULL
subsequent	NULL
induction	NULL
of	NULL
genes	NULL
that	NULL
initiate	NULL
adaptive	NULL
immunity	NULL
,	NULL
such	NULL
as	NULL
IL-8	NULL
.	NULL

Therefore	NULL
,	NULL
TLR2	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
signaling	NULL
molecule	NULL
for	NULL
LPS	NULL
(	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
proximal	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
TLR2	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Here	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
TLR2	NULL
can	NULL
interact	NULL
with	NULL
mCD14	NULL
to	NULL
form	NULL
the	NULL
LPS	NULL
receptor	NULL
complex	NULL
.	NULL

LPS	NULL
treatment	NULL
leads	NULL
to	NULL
receptor	NULL
oligomerization	NULL
and	NULL
to	NULL
subsequent	NULL
recruitment	NULL
of	NULL
IL-1R-associated	NULL
kinase	NULL
(	NULL
IRAK	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
results	NULL
implicate	NULL
myeloid	NULL
differentiation	NULL
protein	NULL
(	NULL
MyD88	NULL
)	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
6	NULL
(	NULL
TRAF6	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B-inducing	NULL
kinase	NULL
(	NULL
NIK	NULL
)	NULL
in	NULL
the	NULL
TLR2-mediated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
C-terminal	NULL
deletion	NULL
variants	NULL
act	NULL
as	NULL
dominant-negative	NULL
(	NULL
DN	NULL
)	NULL
receptors	NULL
in	NULL
that	NULL
they	NULL
can	NULL
form	NULL
complexes	NULL
with	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
TLR2	NULL
but	NULL
fail	NULL
to	NULL
recruit	NULL
IRAK	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Antisera	NULL
The	NULL
entire	NULL
TLR2	NULL
ECD	NULL
fused	NULL
with	NULL
human	NULL
IgG	NULL
Fc	NULL
was	NULL
used	NULL
as	NULL
immunogen	NULL
to	NULL
raise	NULL
anti-TLR2	NULL
polyclonal	NULL
Ab	NULL
.	NULL

Anti-Flag	NULL
M2	NULL
monoclonal	NULL
and	NULL
anti-IRAK	NULL
antiserum	NULL
were	NULL
purchased	NULL
from	NULL
Eastman	NULL
Kodak	NULL
(	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
and	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

FACS	NULL
analysis	NULL
Human	NULL
PBLs	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-diatrizoate	NULL
density	NULL
gradient	NULL
centrifugation	NULL
from	NULL
normal	NULL
volunteer	NULL
donors	NULL
.	NULL

PBLs	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
PBS/2	NULL
%	NULL
BSA	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0.25	NULL
ml	NULL
containing	NULL
PE-conjugated	NULL
CD14	NULL
mAb	NULL
(	NULL
Dako	NULL
,	NULL
1:250	NULL
dilution	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

A	NULL
total	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
purified	NULL
anti-TLR2	NULL
IgG	NULL
and	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
secondary	NULL
Ab	NULL
(	NULL
1/100	NULL
dilution	NULL
;	NULL
Caltag	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
were	NULL
added	NULL
sequentially	NULL
;	NULL
each	NULL
were	NULL
incubated	NULL
for	NULL
40	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

FACS	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
640	NULL
LPS-INDUCED	NULL
TLR2	NULL
OLIGOMERIZATION	NULL
AND	NULL
IRAK	NULL
RECRUITMENT	NULL
Construction	NULL
of	NULL
expression	NULL
plasmids	NULL
The	NULL
amino	NULL
terminal	NULL
epitope	NULL
tag	NULL
version	NULL
of	NULL
mCD14	NULL
(	NULL
gD.mCD14	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
adding	NULL
an	NULL
Xhol	NULL
restriction	NULL
site	NULL
immediately	NULL
upstream	NULL
of	NULL
thre-onine	NULL
at	NULL
position	NULL
21	NULL
(	NULL
the	NULL
first	NULL
amino	NULL
acid	NULL
of	NULL
the	NULL
predicted	NULL
mature	NULL
form	NULL
of	NULL
mCD14	NULL
)	NULL
and	NULL
linking	NULL
this	NULL
to	NULL
amino	NULL
acids	NULL
1-53	NULL
of	NULL
HSV	NULL
type	NULL
1	NULL
glycoprotein	NULL
D	NULL
(	NULL
gD	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Mammalian	NULL
expression	NULL
vectors	NULL
encoding	NULL
DN	NULL
forms	NULL
of	NULL
MyD88-DN	NULL
(	NULL
152-296	NULL
)	NULL
,	NULL
TRAFZ-DN	NULL
(	NULL
87-501	NULL
)	NULL
,	NULL
TRAFG-DN	NULL
(	NULL
289-522	NULL
)	NULL
,	NULL
IRAK-DN	NULL
(	NULL
1-96	NULL
)	NULL
,	NULL
IRAK2-DN	NULL
(	NULL
1-96	NULL
)	NULL
,	NULL
receptor	NULL
interacting	NULL
protein	NULL
(	NULL
RIP	NULL
)	NULL
-DN	NULL
(	NULL
559-671	NULL
)	NULL
,	NULL
and	NULL
NIK-DN	NULL
(	NULL
KK429-430AA	NULL
)	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
15-20	NULL
)	NULL
.	NULL

The	NULL
Flag	NULL
epitope	NULL
(	NULL
DYKDDDDK	NULL
)	NULL
was	NULL
positioned	NULL
at	NULL
amino	NULL
acid	NULL
1	NULL
of	NULL
the	NULL
mature	NULL
form	NULL
of	NULL
TLR2	NULL
by	NULL
oligonu-cleotide-directed	NULL
mutagenesis	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
transfection	NULL
Human	NULL
embryonic	NULL
kidney	NULL
293	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
low	NULL
glucose	NULL
DMEM/HAM	NULL
's	NULL
F12	NULL
(	NULL
50:50	NULL
)	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
ug/ml	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
.	NULL

The	NULL
293	NULL
stable	NULL
cell	NULL
line	NULL
expressing	NULL
an	NULL
epitope-tagged	NULL
version	NULL
of	NULL
TLR2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
transfection	NULL
conditions	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
in	NULL
all	NULL
transfections	NULL
by	NULL
supplementing	NULL
pRK5	NULL
vector	NULL
DNA	NULL
.	NULL

Luciferase	NULL
reporter	NULL
assay	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
plasmids	NULL
together	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
pGL3-ELAM.tk	NULL
and	NULL
0.05	NULL
ug	NULL
of	NULL
the	NULL
Renilla	NULL
luciferase	NULL
reporter	NULL
vector	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
(	NULL
12	NULL
)	NULL
.	NULL

After	NULL
20	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
Escherichia	NULL
coli	NULL
LCD25	NULL
LPS	NULL
(	NULL
50	NULL
ng/ml	NULL
;	NULL
List	NULL
Biological	NULL
Labs	NULL
,	NULL
Campbell	NULL
,	NULL
CA	NULL
)	NULL
supplemented	NULL
with	NULL
LBP	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
6	NULL
h.	NULL
Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
reagents	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
was	NULL
expressed	NULL
as	NULL
relative	NULL
luciferase	NULL
activity	NULL
by	NULL
dividing	NULL
firefly	NULL
luciferase	NULL
activity	NULL
by	NULL
that	NULL
of	NULL
Renilla	NULL
luciferase	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
Transfected	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
at	NULL
100,000	NULL
X	NULL
g.	NULL
Cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
anti-gD	NULL
mAb	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
50	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
protein	NULL
A-agarose	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
gentle	NULL
rocking	NULL
.	NULL

After	NULL
three	NULL
washings	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
precipitated	NULL
complexes	NULL
were	NULL
solubilized	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
fractionated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
PBS	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
and	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
were	NULL
blotted	NULL
with	NULL
the	NULL
indicated	NULL
Abs	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
HRP-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
washing	NULL
the	NULL
membranes	NULL
,	NULL
the	NULL
reactive	NULL
bands	NULL
were	NULL
visualized	NULL
with	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Coexpression	NULL
of	NULL
mCD14	NULL
and	NULL
TLR2	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
leukocytes	NULL
We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
TLR2	NULL
serves	NULL
as	NULL
a	NULL
signal	NULL
transducer	NULL
to	NULL
mediate	NULL
transmembrane	NULL
LPS	NULL
signaling	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mCD14	NULL
,	NULL
when	NULL
coexpressed	NULL
with	NULL
TLR2	NULL
,	NULL
can	NULL
dramatically	NULL
increase	NULL
LPS	NULL
responsiveness	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
mCD14	NULL
and	NULL
TLR2	NULL
are	NULL
coexpressed	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
leukocytes	NULL
by	NULL
using	NULL
FACS	NULL
analysis	NULL
.	NULL

Freshly	NULL
isolated	NULL
human	NULL
PBLs	NULL
were	NULL
incubated	NULL
sequentially	NULL
with	NULL
a	NULL
PE-conjugated	NULL
anti-CD14	NULL
mAb	NULL
and	NULL
an	NULL
unconju-gated	NULL
TLR2	NULL
Ab	NULL
followed	NULL
by	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
secondary	NULL
Ab	NULL
and	NULL
were	NULL
subsequently	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

mCD14	NULL
is	NULL
a	NULL
marker	NULL
for	NULL
monocytes	NULL
,	NULL
and	NULL
we	NULL
observed	NULL
that	NULL
nearly	NULL
all	NULL
mCD14*	NULL
cells	NULL
also	NULL
expressed	NULL
TLR2	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
population	NULL
of	NULL
cells	NULL
was	NULL
detected	NULL
that	NULL
expressed	NULL
TLR2	NULL
but	NULL
not	NULL
m€CD14	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
not	NULL
yet	NULL
characterized	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
two	NULL
subsets	NULL
of	NULL
leukocytes	NULL
,	NULL
either	NULL
expressing	NULL
TLR2	NULL
alone	NULL
or	NULL
coexpressing	NULL
mCD14	NULL
and	NULL
TLR2	NULL
,	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
CD14-independent	NULL
and	NULL
CD14-dependent	NULL
signaling	NULL
pathways	NULL
of	NULL
LPS	NULL
ac	NULL
TLR2	NULL
FIGURE	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
mCD14	NULL
and	NULL
TLR2	NULL
on	NULL
PBLs	NULL
.	NULL

Human	NULL
PBLs	NULL
were	NULL
prepared	NULL
and	NULL
stained	NULL
with	NULL
anti-CD14	NULL
and	NULL
TLR2	NULL
Abs	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
double	NULL
color	NULL
fluorescence	NULL
histograms	NULL
with	NULL
a	NULL
log	NULL
scale	NULL
of	NULL
fluorescence	NULL
intensity	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
two	NULL
subsets	NULL
of	NULL
PBLs	NULL
is	NULL
indicated	NULL
;	NULL
one	NULL
expressed	NULL
only	NULL
TLR2	NULL
,	NULL
and	NULL
the	NULL
other	NULL
contained	NULL
both	NULL
mCD14	NULL
and	NULL
TLR2	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
twice	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

tivation	NULL
observed	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
as	NULL
in	NULL
vitro	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
LPS-responsive	NULL
cells	NULL
may	NULL
use	NULL
soluble	NULL
CD14	NULL
for	NULL
signaling	NULL
.	NULL

TLR2	NULL
associates	NULL
with	NULL
CD14	NULL
,	NULL
and	NULL
LPS	NULL
induces	NULL
receptor	NULL
oligomerization	NULL
and	NULL
association	NULL
of	NULL
IRAK	NULL
We	NULL
subsequently	NULL
examined	NULL
whether	NULL
TLR2	NULL
and	NULL
mCD14	NULL
could	NULL
form	NULL
a	NULL
complex	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
version	NULL
of	NULL
CD14	NULL
containing	NULL
the	NULL
gD	NULL
epitope	NULL
tag	NULL
alone	NULL
(	NULL
gD.mCD14	NULL
)	NULL
or	NULL
with	NULL
Flag-tagged	NULL
versions	NULL
of	NULL
either	NULL
TLR2	NULL
(	NULL
Flag	NULL
.	NULL

TLR2	NULL
)	NULL
or	NULL
,	NULL
as	NULL
a	NULL
control	NULL
,	NULL
IL-1R	NULL
and	NULL
IL-1R	NULL
accessory	NULL
proteins	NULL
(	NULL
Flag.IL-1Rs	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
gD	NULL
epitope	NULL
tag	NULL
,	NULL
and	NULL
coprecipitating	NULL
Flag-tagged	NULL
receptors	NULL
were	NULL
detected	NULL
on	NULL
blots	NULL
with	NULL
an	NULL
anti-Flag	NULL
mAb	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
mCD14	NULL
does	NULL
indeed	NULL
associate	NULL
with	NULL
TLR2	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LPS	NULL
,	NULL
and	NULL
this	NULL
interaction	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
an	NULL
association	NULL
between	NULL
mCD14	NULL
and	NULL
IL-1Rs	NULL
,	NULL
suggesting	NULL
specificity	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
mCD14	NULL
and	NULL
TLR2	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Because	NULL
ligand-induced	NULL
oligomerization	NULL
is	NULL
a	NULL
commonly	NULL
used	NULL
mechanism	NULL
to	NULL
activate	NULL
cytokine	NULL
receptors	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
TLR2	NULL
formed	NULL
oligomers	NULL
upon	NULL
LPS	NULL
treatment	NULL
.	NULL

Flag	NULL
.	NULL

TLR2	NULL
was	NULL
transiently	NULL
expressed	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
stably	NULL
expressed	NULL
a	NULL
gD-tagged	NULL
TLR2	NULL
protein	NULL
(	NULL
gD.TLR2	NULL
)	NULL
.	NULL

We	NULL
detected	NULL
some	NULL
association	NULL
of	NULL
Flag	NULL
.	NULL

TLR2	NULL
with	NULL
gD.TLR2	NULL
in	NULL
untreated	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
interaction	NULL
was	NULL
enhanced	NULL
upon	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
LPS	NULL
receptor	NULL
complex	NULL
between	NULL
mCD14	NULL
and	NULL
TLR2	NULL
is	NULL
reminiscent	NULL
of	NULL
a	NULL
multiple	NULL
chain	NULL
receptor	NULL
complex	NULL
used	NULL
by	NULL
several	NULL
cytokines	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
IL-6/leukemia	NULL
inhibiting	NULL
factor/ciliary	NULL
neurotrophic	NULL
factor	NULL
receptor	NULL
(	NULL
CNTFR	NULL
)	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
ligand-binding	NULL
subunit	NULL
and	NULL
the	NULL
signal	NULL
transducer	NULL
glycoprotein	NULL
130	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
receptors	NULL
for	NULL
CNTF	NULL
(	NULL
CNTFR	NULL
«	NULL
a	NULL
)	NULL
and	NULL
for	NULL
glial	NULL
cell	NULL
line-derived	NULL
neurotrophic	NULL
factor	NULL
(	NULL
glial	NULL
cell	NULL
line-derived	NULL
neurotrophic	NULL
factor	NULL
receptor	NULL
@	NULL
)	NULL
,	NULL
like	NULL
CD14	NULL
,	NULL
are	NULL
also	NULL
GPI-anchored	NULL
proteins	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

The	NULL
Ser/Thr	NULL
kinase	NULL
IRAK	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NF-KB	NULL
by	NULL
IL-1	NULL
and	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
TLR4	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
IRAK	NULL
was	NULL
recruited	NULL
to	NULL
the	NULL
TLR2	NULL
complex	NULL
.	NULL

IRAK	NULL
coprecipitated	NULL
with	NULL
TLR2	NULL
in	NULL
293	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
,	NULL
and	NULL
this	NULL
complex	NULL
reached	NULL
a	NULL
peak	NULL
at	NULL
5	NULL
min	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
association	NULL
of	NULL
TLR2	NULL
with	NULL
IRAK	NULL
recruitment	NULL
closely	NULL
followed	NULL
the	NULL
time	NULL
course	NULL
of	NULL
TLR2	NULL
oligomerization	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
TLR2	NULL
recruits	NULL
IRAK	NULL
,	NULL
and	NULL
suggest	NULL
that	NULL
LPS-induced	NULL
TLR2	NULL
oligomerization	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
for	NULL
TLR2	NULL
signal	NULL
transduction	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
LPS	NULL
may	NULL
induce	NULL
other	NULL
molecular	NULL
events	NULL
,	NULL
such	NULL
as	NULL
the	NULL
recruitment	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
Vector	NULL
4	NULL
*	NULL
gD.mcD14	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Flag	NULL
.	NULL

+	NULL
+	NULL
Flag.IL-1Rs	NULL
hat	NULL
-	NULL
+4	NULL
LPS	NULL
v_-	NULL
«	NULL
<	NULL
Flag.TLR2	NULL
IP	NULL
:	NULL
«	NULL
a	NULL
gD	NULL
_	NULL
WB	NULL
:	NULL
«	NULL
Flag	NULL
n	NULL
<	NULL
gD.mcD14	NULL
IP	NULL
:	NULL
a	NULL
gD	NULL
_	NULL
WB	NULL
:	NULL
a	NULL
gD	NULL
B	NULL
0	NULL
0.50	NULL
10	NULL
§	NULL
10	NULL
[	NULL
min	NULL
]	NULL
120	NULL
-	NULL
«	NULL
--	NULL
<	NULL
Flag.TLR2	NULL
85	NULL
-|	NULL
IP	NULL
:	NULL
a	NULL
gD	NULL
_	NULL
WB	NULL
:	NULL
«	NULL
Flag	NULL
``	NULL
m	NULL
wo	NULL
»	NULL
<	NULL
<	NULL
IRAK	NULL
IP	NULL
:	NULL
a	NULL
gD	NULL
_	NULL
WB	NULL
:	NULL
a	NULL
IRAK	NULL
<	NULL
30.1T._.R2	NULL
IP	NULL
:	NULL
a	NULL
gD	NULL
_	NULL
WB	NULL
:	NULL
a	NULL
gD	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
TLR2	NULL
and	NULL
mCD14	NULL
form	NULL
a	NULL
receptor	NULL
complex	NULL
,	NULL
and	NULL
LPS	NULL
treatment	NULL
induces	NULL
TLR2	NULL
oligomerization	NULL
and	NULL
recruitment	NULL
of	NULL
IRAK	NULL
.	NULL

A	NULL
,	NULL
gD.mCD14	NULL
,	NULL
Flag	NULL
.	NULL

TLR2	NULL
,	NULL
or	NULL
Flag.IL-1Rs	NULL
expression	NULL
plasmids	NULL
were	NULL
transfected	NULL
in	NULL
293	NULL
cells	NULL
as	NULL
indicated	NULL
.	NULL

At	NULL
20	NULL
h	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
or	NULL
left	NULL
unstimu-lated	NULL
.	NULL

Detergent	NULL
(	NULL
60	NULL
mM	NULL
octylglucoside	NULL
plus	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
lysates	NULL
of	NULL
each	NULL
transfection	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-gD	NULL
mAb	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
anti-Flag	NULL
M2	NULL
Ab	NULL
to	NULL
determine	NULL
the	NULL
associated	NULL
proteins	NULL
(	NULL
fop	NULL
)	NULL
.	NULL

B	NULL
,	NULL
293-gD.TLR2	NULL
cells	NULL
transiently	NULL
expressing	NULL
Flag.TLR2	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
length	NULL
of	NULL
time	NULL
.	NULL

TLR2	NULL
complexes	NULL
from	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-gD	NULL
Ab	NULL
and	NULL
immunoblotted	NULL
with	NULL
antiserum	NULL
against	NULL
Flag	NULL
epitope	NULL
(	NULL
top	NULL
)	NULL
or	NULL
IRAK	NULL
(	NULL
middle	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
anti-gD	NULL
immunoblotting	NULL
was	NULL
used	NULL
to	NULL
verify	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
gD.mCD14	NULL
or	NULL
gD.TLR2	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
bottom	NULL
of	NULL
A	NULL
or	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

IP	NULL
,	NULL
immunoprecipitation	NULL
;	NULL
WB	NULL
,	NULL
Western	NULL
blot	NULL
.	NULL

additional	NULL
receptor	NULL
subunits	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
create	NULL
docking	NULL
sites	NULL
for	NULL
more	NULL
signaling	NULL
proteins	NULL
.	NULL

TLR2	NULL
C-terminal	NULL
deletion	NULL
variants	NULL
form	NULL
complexes	NULL
with	NULL
TLR2	NULL
and	NULL
fail	NULL
to	NULL
recruit	NULL
IRAK	NULL
We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
TLR2	NULL
variants	NULL
with	NULL
C-terminal	NULL
deletions	NULL
of	NULL
either	NULL
13	NULL
or	NULL
141	NULL
aa	NULL
(	NULL
TLR2-A1	NULL
and	NULL
TLR2-A2	NULL
,	NULL
respec-tively	NULL
)	NULL
and	NULL
a	NULL
variant	NULL
in	NULL
which	NULL
the	NULL
entire	NULL
ECD	NULL
of	NULL
TLR2	NULL
is	NULL
replaced	NULL
with	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
ECD	NULL
of	NULL
CD4	NULL
(	NULL
CD4.TLR2	NULL
)	NULL
are	NULL
defective	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
NF-KB	NULL
responsive	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
reporter	NULL
gene	NULL
(	NULL
12	NULL
)	NULL
.	NULL

We	NULL
used	NULL
these	NULL
variants	NULL
to	NULL
characterize	NULL
the	NULL
domains	NULL
of	NULL
TLR2	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
TLR2	NULL
oligomerization	NULL
.	NULL

gD-tagged	NULL
TLR2-A1	NULL
,	NULL
TLR2-A2	NULL
,	NULL
or	NULL
CD4.TLR2	NULL
were	NULL
transiently	NULL
coexpressed	NULL
with	NULL
full-length	NULL
Flag-tagged	NULL
TLR2	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
WT	NULL
gD.TLR2	NULL
,	NULL
gD.TLR2-A1	NULL
,	NULL
or	NULL
gD.TLR-A2	NULL
resulted	NULL
in	NULL
the	NULL
coprecipitation	NULL
of	NULL
Flag-tagged	NULL
TLR2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
reciprocal	NULL
immunoprecipitation	NULL
of	NULL
Flag	NULL
.	NULL

results	NULL
in	NULL
the	NULL
coprecipitation	NULL
of	NULL
WTgD.TLR2	NULL
,	NULL
641	NULL
Flag.TLR2	NULL
+	NULL
+	NULL
+	NULL
+	NULL
gD.TLR2	NULL
+	NULL
_	NULL
+	NULL
gD.TLR2-	NULL
A2	NULL
+	NULL
CD4.TLR2	NULL
+	NULL
120	NULL
--	NULL
«	NULL
ctv	NULL
enemee	NULL
«	NULL
«	NULL
Flag	NULL
.	NULL

TLR2	NULL
~	NULL
IP	NULL
:	NULL
agD	NULL
IP	NULL
:	NULL
«	NULL
CD4	NULL
WB	NULL
:	NULL
aFlag	NULL
WB	NULL
:	NULL
aFlag	NULL
e-	NULL
‘	NULL
“	NULL
8	NULL
aw	NULL
s=	NULL
4J	NULL
85	NULL
-	NULL
*	NULL
IP	NULL
:	NULL
agD	NULL
IP	NULL
:	NULL
«	NULL
CD4	NULL
WB	NULL
:	NULL
«	NULL
gD	NULL
WwB	NULL
:	NULL
aCD4	NULL
FIGURE	NULL
3	NULL
.	NULL

Domain	NULL
requirements	NULL
for	NULL
receptor	NULL
interactions	NULL
.	NULL

Flag	NULL
.	NULL

TLR2	NULL
was	NULL
expressed	NULL
together	NULL
with	NULL
gD.TLR2	NULL
,	NULL
gD.TLR2-A1	NULL
,	NULL
gD.TLR2-A2	NULL
,	NULL
or	NULL
CD4.TLR2	NULL
by	NULL
transient	NULL
transfection	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblotting	NULL
were	NULL
performed	NULL
using	NULL
antisera	NULL
as	NULL
indicated	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

gD.TLR2-A1	NULL
or	NULL
gD.TLR2-A2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CD4	NULL
.	NULL

failed	NULL
to	NULL
associate	NULL
with	NULL
WT	NULL
Flag	NULL
.	NULL

TLR2	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
ECD	NULL
is	NULL
required	NULL
for	NULL
receptor	NULL
complex	NULL
formation	NULL
.	NULL

We	NULL
subsequently	NULL
determined	NULL
whether	NULL
the	NULL
C-terminal	NULL
truncation	NULL
variants	NULL
of	NULL
TLR2	NULL
were	NULL
defective	NULL
in	NULL
the	NULL
recruitment	NULL
of	NULL
IRAK	NULL
.	NULL

The	NULL
full-length	NULL
TLR2	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
two	NULL
deletion	NULL
constructs	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
and	NULL
receptor	NULL
complexes	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-IRAK	NULL
antiserum	NULL
.	NULL

Whereas	NULL
the	NULL
WT	NULL
TLR2	NULL
showed	NULL
LPS-inducible	NULL
IRAK	NULL
recruitment	NULL
,	NULL
TLR2Z-Al1	NULL
or	NULL
TLR2-A2	NULL
failed	NULL
to	NULL
associate	NULL
with	NULL
IRAK	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
C-terminal	NULL
region	NULL
of	NULL
13	NULL
aa	NULL
that	NULL
is	NULL
deleted	NULL
in	NULL
TLR2-A1	NULL
is	NULL
homol-ogous	NULL
to	NULL
a	NULL
region	NULL
of	NULL
the	NULL
IL-1R	NULL
that	NULL
is	NULL
required	NULL
for	NULL
association	NULL
with	NULL
IRAK	NULL
.	NULL

Likewise	NULL
,	NULL
this	NULL
carboxyl-terminal	NULL
tail	NULL
of	NULL
TLR2	NULL
appears	NULL
essential	NULL
for	NULL
IRAK	NULL
recruitment	NULL
and	NULL
subsequent	NULL
signal	NULL
transduction	NULL
.	NULL

TLR2-A1	NULL
and	NULL
TLR2-A2	NULL
abrogate	NULL
WT	NULL
TLR2-induced	NULL
NF-kB	NULL
activity	NULL
in	NULL
293	NULL
cells	NULL
The	NULL
ability	NULL
of	NULL
A1	NULL
or	NULL
A2	NULL
to	NULL
form	NULL
heteromers	NULL
with	NULL
WT	NULL
TLR2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
coupled	NULL
with	NULL
their	NULL
failure	NULL
to	NULL
recruit	NULL
IRAK	NULL
suggests	NULL
that	NULL
these	NULL
TLR2-WT	NULL
-	NULL
+	NULL
hat	NULL
TLR2-	NULL
A1	NULL
*	NULL
+	NULL
TLR2-	NULL
A	NULL
2	NULL
4+	NULL
#	NULL
|	NULL
|	NULL
Sh	NULL
|	NULL
in	NULL
LPS	NULL
WW	NULL
?	NULL

?	NULL

?	NULL

IRAK	NULL
|	NULL
oe	NULL
«	NULL
IRAK	NULL
IP	NULL
:	NULL
«	NULL
a	NULL
gD	NULL
unite	NULL
qnemce	NULL
doer	NULL
cme	NULL
<	NULL
TLR2WT	NULL
or	NULL
A1	NULL
WB	NULL
:	NULL
a	NULL
gD	NULL
f	NULL
anl	NULL
WWD	NULL
<	NULL
TLR2-A2	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Carboxyl-terminal	NULL
tail	NULL
of	NULL
TLR2	NULL
is	NULL
required	NULL
for	NULL
recruitment	NULL
of	NULL
IRAK	NULL
upon	NULL
LPS	NULL
stimulation	NULL
.	NULL

gD-tagged	NULL
full-length	NULL
TLR2-WT	NULL
,	NULL
TLR2-A1	NULL
,	NULL
or	NULL
TLR2-A2	NULL
was	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
by	NULL
transient	NULL
transfection	NULL
(	NULL
1	NULL
ug	NULL
DNA	NULL
of	NULL
each	NULL
construct	NULL
)	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-gD	NULL
Ab	NULL
.	NULL

Immu-nocomplexes	NULL
were	NULL
blotted	NULL
with	NULL
antiserum	NULL
to	NULL
IRAK	NULL
or	NULL
the	NULL
gD	NULL
epitope	NULL
,	NULL
respectively	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
642	NULL
LPS-INDUCED	NULL
TLR2	NULL
OLIGOMERIZATION	NULL
AND	NULL
IRAK	NULL
RECRUITMENT	NULL
8	NULL
&	NULL
1	NULL
C-	NULL
Vector	NULL
R	NULL
TLR2-	NULL
M1	NULL
mad	NULL
TLR2-	NULL
A2	NULL
m	NULL
TLRZ-WT	NULL
20	NULL
15	NULL
10	NULL
Relative	NULL
luciferase	NULL
activity	NULL
A	NULL
5	NULL
1.0	NULL
(	NULL
ug	NULL
)	NULL
thn	NULL
wo	NULL
we	NULL
aut	NULL
Poles	NULL
B	NULL
)	NULL
Bee	NULL
lik	NULL
-	NULL
Tore	NULL
wt	NULL
or	NULL
a1	NULL
tum	NULL
da	NULL
-	NULL
TLR2-A2	NULL
FIGURE	NULL
5	NULL
.	NULL

DN	NULL
effect	NULL
of	NULL
intracellular	NULL
deletion	NULL
mutants	NULL
(	NULL
TLR2-A1	NULL
or	NULL
TLR2-A2	NULL
)	NULL
on	NULL
WT	NULL
receptor	NULL
signaling	NULL
.	NULL

Left	NULL
,	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
TLR2-WT	NULL
.	NULL

Right	NULL
,	NULL
TLR2	NULL
deletion	NULL
mutants	NULL
(	NULL
TLR2-A1	NULL
or	NULL
TLR2-A2	NULL
)	NULL
function	NULL
in	NULL
a	NULL
DN	NULL
fashion	NULL
when	NULL
coexpressed	NULL
with	NULL
TLR2-WT	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
LPS-responsive	NULL
enhancer	NULL
of	NULL
the	NULL
IL-8	NULL
gene	NULL
along	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
(	NULL
pRK5	NULL
)	NULL
or	NULL
TLR2	NULL
expression	NULL
plasmids	NULL
(	NULL
Zeff	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
0.1	NULL
pg	NULL
of	NULL
TLR2-WT	NULL
,	NULL
0.1	NULL
,	NULL
0.5	NULL
,	NULL
or	NULL
1.0	NULL
ug	NULL
of	NULL
TLR2-WT	NULL
,	NULL
TLR2-A1	NULL
,	NULL
or	NULL
TLR2-A2	NULL
expression	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
in	NULL
293	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
reporter	NULL
plasmids	NULL
.	NULL

At	NULL
20	NULL
h	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
LPS	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
for	NULL
6	NULL
h	NULL
and	NULL
subsequently	NULL
lysed	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
monitored	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-gD	NULL
Ab	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
anti-gD	NULL
Ab	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

TLR2-WT	NULL
and	NULL
TLR2-A1	NULL
migrated	NULL
at	NULL
the	NULL
same	NULL
apparent	NULL
m.w	NULL
.	NULL

variants	NULL
might	NULL
act	NULL
as	NULL
DN	NULL
proteins	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
cotransfected	NULL
A1	NULL
or	NULL
A2	NULL
with	NULL
WT	NULL
TLR2	NULL
and	NULL
examined	NULL
their	NULL
effects	NULL
on	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

Whereas	NULL
expression	NULL
of	NULL
WT	NULL
TLR2	NULL
resulted	NULL
in	NULL
LPS	NULL
responsiveness	NULL
,	NULL
coexpression	NULL
of	NULL
A1	NULL
or	NULL
A2	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
blocking	NULL
of	NULL
TLR2-mediated	NULL
NF-KB	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
these	NULL
intracellular	NULL
deletion	NULL
variants	NULL
can	NULL
serve	NULL
as	NULL
DN	NULL
receptors	NULL
and	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
TLR2	NULL
is	NULL
capable	NULL
of	NULL
forming	NULL
oligomers	NULL
in	NULL
the	NULL
overexpressing	NULL
293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
WT	NULL
TLR2	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunoblots	NULL
,	NULL
remained	NULL
unchanged	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
A2	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
residual	NULL
NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
gene	NULL
activity	NULL
seen	NULL
during	NULL
the	NULL
coexpression	NULL
of	NULL
WT	NULL
and	NULL
the	NULL
deletion	NULL
variants	NULL
of	NULL
TLR2	NULL
is	NULL
probably	NULL
mediated	NULL
by	NULL
a	NULL
portion	NULL
of	NULL
homomeric	NULL
WT	NULL
TLR2	NULL
.	NULL

MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
participate	NULL
in	NULL
TLR2-mediated	NULL
NF-KB	NULL
induction	NULL
Recent	NULL
studies	NULL
have	NULL
revealed	NULL
the	NULL
proximal	NULL
signaling	NULL
events	NULL
leading	NULL
to	NULL
IL-1	NULL
-induced	NULL
NF-KB	NULL
activation	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
receptor-associated	NULL
adapter	NULL
protein	NULL
,	NULL
MyD88	NULL
,	NULL
recruits	NULL
IRAK	NULL
and	NULL
IRAK2	NULL
to	NULL
the	NULL
receptor	NULL
complexes	NULL
.	NULL

IRAK	NULL
and	NULL
IRAK2	NULL
then	NULL
interact	NULL
with	NULL
another	NULL
cytoplasmic	NULL
adapter	NULL
protein	NULL
named	NULL
TRAF6	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
relays	NULL
a	NULL
signal	NULL
through	NULL
the	NULL
NIK	NULL
to	NULL
I-	NULL
«	NULL
B	NULL
kinases	NULL
1	NULL
and	NULL
2	NULL
,	NULL
leading	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
version	NULL
of	NULL
TLR4	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
conservation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
TLR2	NULL
and	NULL
the	NULL
IL-1R	NULL
family	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
TLR2-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
requires	NULL
the	NULL
signaling	NULL
components	NULL
that	NULL
are	NULL
known	NULL
to	NULL
be	NULL
used	NULL
in	NULL
the	NULL
IL-1	NULL
pathway	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
DN	NULL
versions	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
TRAF6	NULL
,	NULL
or	NULL
NIK	NULL
attenuated	NULL
TLR2-mediated	NULL
NF-KB	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Activation	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
DN	NULL
versions	NULL
of	NULL
IRAK2	NULL
,	NULL
TRAF2	NULL
,	NULL
or	NULL
RIP	NULL
.	NULL

TRAF2	NULL
and	NULL
RIP	NULL
are	NULL
0.6	NULL
|-	NULL
I	NULL
_	NULL
05	NULL
F-	NULL
i	NULL
3	NULL
c-	NULL
[	NULL
-E	NULL
o	NULL
04	NULL
}	NULL
Fu	NULL
§	NULL
£	NULL
C	NULL
0.3	NULL
f	NULL
G	NULL
p	NULL
f	NULL
2	NULL
T	NULL
0.2	NULL
}	NULL
o	NULL
r	NULL
01	NULL
F-0-0	NULL
I	NULL
I	NULL
I	NULL
¥	NULL
I	NULL
I	NULL
L	NULL
l-T	NULL
‘	NULL
TLR2	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
701	NULL
ug	NULL
MyD88-DN	NULL
_	NULL
+	NULL
TRAF2-DN	NULL
+	NULL
TRAFE-DN	NULL
+	NULL
IRAK-DN	NULL
+	NULL
IRAK2-DN	NULL
+	NULL
RIP-DN	NULL
+	NULL
NIK-DN	NULL
+	NULL
0.5	NULL
ug	NULL
FIGURE	NULL
6	NULL
.	NULL

Effects	NULL
of	NULL
various	NULL
DN	NULL
signaling	NULL
proteins	NULL
on	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
expression	NULL
plasmids	NULL
together	NULL
with	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
for	NULL
20	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
6-h	NULL
treatment	NULL
of	NULL
LPS	NULL
at	NULL
50	NULL
ng/ml	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LBP	NULL
in	NULL
serum-free	NULL
medium	NULL
.	NULL

Vector	NULL
control	NULL
showed	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
relative	NULL
luciferase	NULL
activity	NULL
at	NULL
0.06	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
duplicate	NULL
experiments	NULL
.	NULL

signaling	NULL
molecules	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
TNF	NULL
,	NULL
whereas	NULL
IRAK2	NULL
binds	NULL
to	NULL
IL-1R1	NULL
.	NULL

These	NULL
results	NULL
implicate	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
in	NULL
signaling	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
TLR2Z	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
showed	NULL
that	NULL
DN	NULL
versions	NULL
of	NULL
MyD88	NULL
,	NULL
IRAK	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
but	NULL
not	NULL
TRAF2	NULL
inhibited	NULL
LPS-induced	NULL
NF-KB	NULL
activity	NULL
in	NULL
human	NULL
dermal	NULL
microvessel	NULL
endothelial	NULL
and	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

We	NULL
reproducibly	NULL
observed	NULL
that	NULL
NIK-DN	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
of	NULL
TLR2	NULL
activity	NULL
than	NULL
IRAK-DN	NULL
or	NULL
TRAFG-DN	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
these	NULL
results	NULL
that	NULL
is	NULL
currently	NULL
being	NULL
investigated	NULL
is	NULL
that	NULL
there	NULL
are	NULL
IRAK-	NULL
and	NULL
TRAF6-independent	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NIK	NULL
;	NULL
thus	NULL
,	NULL
DN	NULL
versions	NULL
of	NULL
IRAK	NULL
or	NULL
TRAFG	NULL
only	NULL
partially	NULL
block	NULL
NF-kB	NULL
activation	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
dissected	NULL
the	NULL
early	NULL
signaling	NULL
events	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
TLR2	NULL
by	NULL
LPS	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
TLR2	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
CD14	NULL
before	NULL
LPS	NULL
treatment	NULL
,	NULL
and	NULL
that	NULL
LPS	NULL
treatment	NULL
results	NULL
in	NULL
TLR2	NULL
oligomerization	NULL
and	NULL
concomitant	NULL
recruitment	NULL
of	NULL
IRAK	NULL
to	NULL
the	NULL
signaling	NULL
complex	NULL
,	NULL
at	NULL
least	NULL
in	NULL
overexpressing	NULL
293	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
now	NULL
of	NULL
interest	NULL
to	NULL
verify	NULL
whether	NULL
such	NULL
signaling	NULL
events	NULL
occur	NULL
in	NULL
native	NULL
lymphoid	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TLR2	NULL
shares	NULL
a	NULL
common	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
NF-B	NULL
activation	NULL
with	NULL
the	NULL
IL-1R	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
IRAK	NULL
,	NULL
MyD88	NULL
,	NULL
TRAF6	NULL
,	NULL
and	NULL
NIK	NULL
in	NULL
TLR2	NULL
signaling	NULL
appears	NULL
to	NULL
extend	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TLR	NULL
family	NULL
,	NULL
such	NULL
as	NULL
TLR4	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Recent	NULL
molecular	NULL
genetic	NULL
data	NULL
suggested	NULL
that	NULL
TLR4	NULL
also	NULL
participates	NULL
in	NULL
the	NULL
LPS	NULL
response	NULL
,	NULL
although	NULL
this	NULL
remains	NULL
to	NULL
be	NULL
demonstrated	NULL
at	NULL
cellular	NULL
or	NULL
biochemical	NULL
levels	NULL
(	NULL
33-35	NULL
)	NULL
.	NULL

TLRs	NULL
and	NULL
IL-1Rs	NULL
appear	NULL
to	NULL
define	NULL
a	NULL
receptor	NULL
superfamily	NULL
that	NULL
uses	NULL
overlapping	NULL
signaling	NULL
components	NULL
to	NULL
orchestrate	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
inflammation	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
References	NULL
1.	NULL
g	NULL
ta	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Rock	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
G.	NULL
Hardiman	NULL
,	NULL
J.	NULL
C.	NULL
Timans	NULL
,	NULL
R.	NULL
A.	NULL
Kastelein	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Bazan	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
family	NULL
of	NULL
human	NULL
receptors	NULL
structurally	NULL
related	NULL
to	NULL
Drosophila	NULL
Toll	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:588.	NULL
.	NULL

Morisato	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
K.	NULL
V.	NULL
Anderson	NULL
.	NULL

1995	NULL
.	NULL

Signaling	NULL
pathways	NULL
that	NULL
establish	NULL
the	NULL
dorsal-ventral	NULL
pattern	NULL
of	NULL
the	NULL
Drosophila	NULL
embryo	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Genet	NULL
.	NULL

29:371.	NULL
.	NULL

Lemaitre	NULL
,	NULL
B.	NULL
,	NULL
J.	NULL
M.	NULL
Reichhart	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hoffmann	NULL
.	NULL

1997	NULL
.	NULL

Drosophila	NULL
host	NULL
de-	NULL
fense	NULL
:	NULL
differential	NULL
induction	NULL
of	NULL
antimicrobial	NULL
peptide	NULL
genes	NULL
after	NULL
infection	NULL
by	NULL
various	NULL
classes	NULL
of	NULL
microorganisms	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:14614.	NULL
.	NULL

Lemaitre	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Nicolas	NULL
,	NULL
L.	NULL
Michaut	NULL
,	NULL
J.	NULL
M.	NULL
Reichhart	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Hoffmann	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
dorsoventral	NULL
regulatory	NULL
gene	NULL
cassette	NULL
spatzle/Toll/cactus	NULL
controls	NULL
the	NULL
potent	NULL
antifungal	NULL
response	NULL
in	NULL
Drosophila	NULL
adults	NULL
.	NULL

Cell	NULL
86:973.	NULL
.	NULL

Bone	NULL
,	NULL
R.	NULL
C.	NULL
1991	NULL
.	NULL

Gram-negative	NULL
sepsis	NULL
.	NULL

Chest	NULL
100:802.	NULL
.	NULL

Rictschel	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
and	NULL
H.	NULL
Brade	NULL
.	NULL

1992	NULL
.	NULL

Bacterial	NULL
endotoxins	NULL
.	NULL

Sci	NULL
.	NULL

Am	NULL
.	NULL

267:54.	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
A.	NULL
Ramos	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Mathison	NULL
.	NULL

1990	NULL
.	NULL

CD14	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
complexes	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
249:1431.	NULL
.	NULL

Schumann	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
S.	NULL
R.	NULL
Leong	NULL
,	NULL
G.	NULL
W.	NULL
Flaggs	NULL
,	NULL
P.	NULL
W.	NULL
Gray	NULL
,	NULL
S.	NULL
D.	NULL
Wright	NULL
,	NULL
J.	NULL
C.	NULL
Mathison	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1990	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
lipopolysaccharide	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
249	NULL
:	NULL
1429.	NULL
.	NULL

Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Tobias	NULL
.	NULL

1995	NULL
.	NULL

Receptor-dependent	NULL
mechanisms	NULL
of	NULL
cell	NULL
stimulation	NULL
by	NULL
bacterial	NULL
endotoxin	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:437	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Preston-Hurlburt	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Janeway	NULL
,	NULL
Jr.	NULL
1997	NULL
.	NULL

A	NULL
human	NULL
ho-mologue	NULL
of	NULL
the	NULL
Drosophila	NULL
Toll	NULL
protein	NULL
signals	NULL
activation	NULL
of	NULL
adaptive	NULL
immunity	NULL
.	NULL

Nature	NULL
388:394	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Janeway	NULL
,	NULL
Jr.	NULL
1998	NULL
.	NULL

Self-defense	NULL
:	NULL
the	NULL
fruit	NULL
fly	NULL
style	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:429	NULL
.	NULL

Yang	NULL
,	NULL
R.-B	NULL
.	NULL

,	NULL
M.	NULL
R.	NULL
Mark	NULL
,	NULL
A	NULL
.	NULL

Gray	NULL
,	NULL
A.	NULL
Huang	NULL
,	NULL
M.	NULL
H.	NULL
Xie	NULL
,	NULL
M.	NULL
Zhang	NULL
,	NULL
A.	NULL
Goddard	NULL
,	NULL
W.	NULL
I	NULL
.	NULL

Wood	NULL
,	NULL
A.	NULL
L.	NULL
Gurney	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Godowski	NULL
.	NULL

1998	NULL
.	NULL

Toll-like	NULL
receptor-2	NULL
mediates	NULL
lipopolysaccharide-induced	NULL
cellular	NULL
signaling	NULL
.	NULL

Nature	NULL
395:284	NULL
.	NULL

Kirschning	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
H.	NULL
Wesche	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
and	NULL
M.	NULL
Rothe	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
Toll-like	NULL
receptor	NULL
2	NULL
confers	NULL
responsiveness	NULL
to	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:2091	NULL
.	NULL

Mark	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
D.	NULL
T.	NULL
Scadden	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
Q.	NULL
Gu	NULL
,	NULL
A.	NULL
Goddard	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Godowski	NULL
.	NULL

1994.	NULL
rse	NULL
,	NULL
a	NULL
novel	NULL
receptor-type	NULL
tyrosine	NULL
kinase	NULL
with	NULL
homology	NULL
to	NULL
Axl/Ufo	NULL
,	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
the	NULL
brain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:10720	NULL
.	NULL

Malinin	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
M.	NULL
P.	NULL
Boldin	NULL
,	NULL
A.	NULL
V.	NULL
Kovalenko	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1997	NULL
.	NULL

MAP3K-related	NULL
kinase	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
by	NULL
TNF	NULL
,	NULL
CD95	NULL
,	NULL
and	NULL
IL-1	NULL
.	NULL

Nature	NULL
385:540	NULL
.	NULL

Wesche	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
I.	NULL
Henzel	NULL
,	NULL
W.	NULL
Shillinglaw	NULL
,	NULL
S.	NULL
Li	NULL
,	NULL
and	NULL
Z.	NULL
Cao	NULL
.	NULL

1997	NULL
.	NULL

MyD88	NULL
:	NULL
an	NULL
adapter	NULL
that	NULL
recruits	NULL
IRAK	NULL
to	NULL
the	NULL
IL-1	NULL
receptor	NULL
complex	NULL
.	NULL

Immunity	NULL
7:837	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-mediated	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
M.	NULL
Takeuchi	NULL
,	NULL
T.	NULL
Kurama	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

TRAF6	NULL
is	NULL
a	NULL
signal	NULL
transducer	NULL
for	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
383:443	NULL
.	NULL

Ting	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
F.	NULL
X.	NULL
Pimentel-Muinos	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1996	NULL
.	NULL

RIP	NULL
mediates	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
1	NULL
activation	NULL
of	NULL
NF-kB	NULL
but	NULL
not	NULL
Fas/APO-1-initiated	NULL
apo-ptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6189	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
P.	NULL
Feng	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1997	NULL
.	NULL

IRAK	NULL
(	NULL
pelle	NULL
)	NULL
family	NULL
member	NULL
IRAK-2	NULL
and	NULL
MyD88	NULL
as	NULL
proximal	NULL
mediators	NULL
of	NULL
IL-1	NULL
signaling	NULL
.	NULL

Science	NULL
278:1612	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

643	NULL
Haziot	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Ferrero	NULL
,	NULL
F.	NULL
Konigen	NULL
,	NULL
N.	NULL
Hijiya	NULL
,	NULL
S.	NULL
Yamamoto	NULL
,	NULL
J	NULL
.	NULL

Silver	NULL
,	NULL
C.	NULL
L.	NULL
Stewart	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Goyert	NULL
.	NULL

1996	NULL
.	NULL

Resistance	NULL
to	NULL
endotoxin	NULL
shock	NULL
and	NULL
reduced	NULL
dissemination	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
in	NULL
CD14-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:407	NULL
.	NULL

Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
.	NULL

1998	NULL
.	NULL

LPS-binding	NULL
proteins	NULL
and	NULL
receptors	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

64:25	NULL
.	NULL

Lemmon	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
signal	NULL
transduction	NULL
and	NULL
signal	NULL
diversity	NULL
by	NULL
receptor	NULL
oligomerization	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19:459	NULL
.	NULL

Murakami	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
N.	NULL
Nakagawa	NULL
,	NULL
T.	NULL
Nakagawa	NULL
,	NULL
K.	NULL
Yasukawa	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1993	NULL
.	NULL

IL-6-induced	NULL
homodimerization	NULL
of	NULL
gp130	NULL
and	NULL
associated	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Science	NULL
260:1808	NULL
.	NULL

Davis	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
H.	NULL
Aldrich	NULL
,	NULL
N.	NULL
Stahl	NULL
,	NULL
L.	NULL
Pan	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
N.	NULL
Y.	NULL
Ip	NULL
,	NULL
and	NULL
G.	NULL
D.	NULL
Yancopoulos	NULL
.	NULL

1993	NULL
.	NULL

LIFRB	NULL
and	NULL
gp130	NULL
as	NULL
heterodimerizing	NULL
signal	NULL
transducers	NULL
of	NULL
the	NULL
tripartite	NULL
CNTF	NULL
receptor	NULL
.	NULL

Science	NULL
260:1805	NULL
.	NULL

Klein	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
D.	NULL
Sherman	NULL
,	NULL
W.	NULL
H.	NULL
Ho	NULL
,	NULL
D.	NULL
Stone	NULL
,	NULL
G.	NULL
L.	NULL
Bennett	NULL
,	NULL
B.	NULL
Moffat	NULL
,	NULL
R.	NULL
Vandlen	NULL
,	NULL
L.	NULL
Simmons	NULL
,	NULL
Q.	NULL
Gu	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hongo	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
GPT-linked	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
Ret	NULL
to	NULL
form	NULL
a	NULL
candidate	NULL
neurturin	NULL
receptor	NULL
.	NULL

Nature	NULL
387:717	NULL
.	NULL

Buj-Bello	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Adu	NULL
,	NULL
L.	NULL
G.	NULL
Pinon	NULL
,	NULL
A.	NULL
Horton	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
A.	NULL
Rosenthal	NULL
,	NULL
M.	NULL
Chinchetru	NULL
,	NULL
V.	NULL
L.	NULL
Buchman	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Davies	NULL
.	NULL

1997	NULL
.	NULL

Neurturin	NULL
responsiveness	NULL
requires	NULL
a	NULL
GPT-linked	NULL
receptor	NULL
and	NULL
the	NULL
Ret	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Nature	NULL
387:721	NULL
.	NULL

Medzhitov	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Preston-Hurlburt	NULL
,	NULL
E.	NULL
Kopp	NULL
,	NULL
A.	NULL
Stadlen	NULL
,	NULL
C.	NULL
Chen	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Janeway	NULL
,	NULL
Jr.	NULL
1998	NULL
.	NULL

MyD88	NULL
is	NULL
an	NULL
adaptor	NULL
protein	NULL
in	NULL
the	NULL
hToll/IL-1	NULL
receptor	NULL
family	NULL
signaling	NULL
pathways	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
2:253	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Natoli	NULL
,	NULL
S.	NULL
Saccani	NULL
,	NULL
M.	NULL
Levrero	NULL
,	NULL
and	NULL
A.	NULL
Mantovani	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
human	NULL
Toll	NULL
signaling	NULL
pathway	NULL
:	NULL
divergence	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
and	NULL
JNK/SAPK	NULL
activation	NULL
upstream	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
factor	NULL
6	NULL
(	NULL
TRAF6	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:2097	NULL
.	NULL

O'Neill	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
C.	NULL
Greene	NULL
.	NULL

1998	NULL
.	NULL

Signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
by	NULL
the	NULL
IL-1	NULL
receptor	NULL
family	NULL
:	NULL
ancient	NULL
signaling	NULL
machinery	NULL
in	NULL
mammals	NULL
,	NULL
insects	NULL
,	NULL
and	NULL
plants	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

63:650	NULL
.	NULL

Burns	NULL
,	NULL
K.	NULL
,	NULL
F.	NULL
Martinon	NULL
,	NULL
C.	NULL
Essling	NULL
,	NULL
H.	NULL
Pahl	NULL
,	NULL
P.	NULL
Schneider	NULL
,	NULL
J.-L.	NULL
Bodmer	NULL
,	NULL
F.	NULL
D.	NULL
Marco	NULL
,	NULL
L.	NULL
French	NULL
,	NULL
and	NULL
J.	NULL
Tschopp	NULL
.	NULL

1998	NULL
.	NULL

MyD88	NULL
,	NULL
an	NULL
adaptor	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-1	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:12203	NULL
.	NULL

Zhang	NULL
,	NULL
F.	NULL
X.	NULL
,	NULL
C.	NULL
J.	NULL
Kirschning	NULL
,	NULL
R.	NULL
Mancinelli	NULL
,	NULL
X.-P.	NULL
Xu	NULL
,	NULL
Y.	NULL
Jin	NULL
,	NULL
E.	NULL
Faure	NULL
,	NULL
A.	NULL
Mantovani	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
M.	NULL
Muzio	NULL
,	NULL
and	NULL
M.	NULL
Arditi	NULL
.	NULL

1999	NULL
.	NULL

Bacterial	NULL
lipopolysaccharide	NULL
activates	NULL
nuclear	NULL
factor-xB	NULL
through	NULL
interleukin-1	NULL
signaling	NULL
mediators	NULL
in	NULL
cultured	NULL
human	NULL
dermal	NULL
endothelial	NULL
cells	NULL
and	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:7611	NULL
.	NULL

Poltorak	NULL
,	NULL
A.	NULL
,	NULL
I	NULL
Smimova	NULL
,	NULL
X	NULL
.	NULL

He	NULL
,	NULL
M.-Y	NULL
.	NULL

Liu	NULL
,	NULL
C.	NULL
Van	NULL
Huffel	NULL
,	NULL
D.	NULL
Birdwell	NULL
,	NULL
E.	NULL
Algjos	NULL
,	NULL
M.	NULL
Silva	NULL
,	NULL
X	NULL
.	NULL

Du	NULL
,	NULL
P.	NULL
Thompson	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Genetic	NULL
and	NULL
physical	NULL
mapping	NULL
of	NULL
the	NULL
Lps	NULL
locus	NULL
:	NULL
identification	NULL
of	NULL
the	NULL
Toll-4	NULL
receptor	NULL
as	NULL
a	NULL
candidate	NULL
gene	NULL
in	NULL
the	NULL
critical	NULL
region	NULL
.	NULL

Blood	NULL
Cells	NULL
Mol	NULL
.	NULL

Dis	NULL
.	NULL

24:340	NULL
.	NULL

Poltorak	NULL
,	NULL
A.	NULL
,	NULL
X	NULL
.	NULL

He	NULL
,	NULL
I.	NULL
Smirnova	NULL
,	NULL
M.-Y	NULL
.	NULL

Liu	NULL
,	NULL
C.	NULL
Van	NULL
Huffel	NULL
,	NULL
X	NULL
.	NULL

Du	NULL
,	NULL
D.	NULL
Birdwell	NULL
,	NULL
E.	NULL
Algjos	NULL
,	NULL
M.	NULL
Silva	NULL
,	NULL
C.	NULL
Galanos	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Defective	NULL
LPS	NULL
signaling	NULL
in	NULL
C3H/HeJ	NULL
and	NULL
C57BL/10ScCr	NULL
mice	NULL
:	NULL
mutations	NULL
in	NULL
Tir4	NULL
gene	NULL
.	NULL

Science	NULL
282:2085	NULL
.	NULL

Qureshi	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
L.	NULL
Lariviere	NULL
,	NULL
G.	NULL
Leveque	NULL
,	NULL
S.	NULL
Clermont	NULL
,	NULL
K.	NULL
J.	NULL
Moore	NULL
,	NULL
P.	NULL
Gros	NULL
,	NULL
and	NULL
D.	NULL
Malo	NULL
.	NULL

1999	NULL
.	NULL

Endotoxin-tolerant	NULL
mice	NULL
have	NULL
mutations	NULL
in	NULL
Toll-like	NULL
receptor	NULL
4	NULL
(	NULL
Tir4	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

189:615	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

